Press Releases YUMAB and MOLCURE Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets
Case Study Discovery of a therapeutic antibody for the treatment of inflammatory bowel disease and type I diabetes
Social wall